- Hamzah Abu-Sbeih, Faisal Shaukat Ali, Emmanuel Coronel, Hsiang-Chun Chen, Xuemei Wang, Phillip Lum, Gladis Shuttlesworth, Manoop S. Bhutani, Gottumukkala S. Raju, Jeffrey H. Lee, John Stroehlein, William A. Ross, Yinghong Wang

Cancer patients are prone to thrombocytopenia and neutropenia, which increase the risk of bleeding and infection. We assessed the safety of endoscopic procedures in cancer patients with thrombocytopenia and/or neutropenia. [...]

- Robert K. Parker, Sinkeet S. Ranketi, Calvin McNelly, Matilda Ongondi, Hillary M. Topazian, Sanford M. Dawsey, Gwen A. Murphy, Russell E. White, Michael Mwachiro


- Tarek Sawas, Mouaz Alsawas, Fateh Bazerbachi, Prasad G. Iyer, Kenneth K. Wang, M. Hassan Murad, David A. Katzka

Endoscopic eradication therapy (EET) is the main treatment for dysplastic Barrett’s esophagus and intramucosal adenocarcinoma. Although the goal of EET is to achieve complete remission of intestinal metaplasia (CRIM), treatment might achieve complete remission of dysplasia (CR-D) only, without achieving CRIM. Persistent intestinal metaplasia after eradication of dysplasia might carry a higher risk for progression into advanced neoplasia. [...]

- Alberto Baptista, Diogo Turiani Hourneaux De Moura, Pichamol Jirapinyo, Eduardo Guimarães Hourneaux De Moura, Andres Gelrud, Michel Kahaleh, Alberto Salinas, Luis Carlos Sabagh, Andrés O. Jaramillo, Víctor Zambrano Rincones, Raul Doval, Jack William Bandel, Christopher C. Thompson

Endoscopy has evolved to become first-line therapy for the treatment of post-bariatric leaks; however, many sessions are often required with variable success rates. Due to these limitations, the use of the cardiac septal defect occluder (CSDO) has recently been reported in this population. [...]

- Kyoko Wada, Michael J. Szego

Patients with a do not resuscitate (DNR) order may go through relatively invasive procedures such as surgery or endoscopy for symptom control. Although there is a robust body of literature on revisiting DNR orders before surgical procedures, there is a scarcity of literature discussing this issue for endoscopy.1,2 We identified this gap after a clinical ethics consultation with the GI clinic team at one of the healthcare institutions affiliated with the Centre for Clinical Ethics. [...]

- Vinod Kumar, Heather Broadley, Douglas K. Rex

Excision of all visible neoplastic tissue is the goal of endoscopic mucosal resection (EMR) of colorectal laterally spreading tumors (LSTs). Flat and fibrotic tissue can resist snaring. Ablation of visible polyps is associated with high recurrence rates. Avulsion is a technique to continue resection when snaring fails. [...]

- Myeongsook Seo, Eun Mi Song, Jin Woong Cho, Young Jae Lee, Bo-In Lee, Jin Su Kim, Seong Woo Jeon, Hyun Joo Jang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon

Delayed bleeding is an important adverse event after colorectal endoscopic submucosal dissection (ESD). We aimed to investigate the incidence and risk factors of delayed bleeding after colorectal ESD, and to develop a risk scoring model for predicting delayed bleeding. [...]

- Roy Soetikno, Jennifer M. Kolb, Tiffany Nguyen-Vu, Channa R. Jayasekera, Roel Bogie, Jessica Yu, Ravishankar Asokkumar, Silvia Sanduleanu, Tonya Kaltenbach


- Anjuli K. Luthra, Kishan Patel, Feng Li, Jeffrey R. Groce, Luis Lara, Sebastian Strobel, Amy Hosmer, Alice Hinton, Darwin L. Conwell, Somashekar G. Krishna

Acute biliary pancreatitis (ABP) is associated with increased rates of morbidity in pregnancy. Because there is a paucity of population-based studies evaluating ABP in pregnancy, we sought to investigate clinical outcomes in hospitalized pregnant women on a national level. [...]

- Lobke Desomer, David J. Tate, Farzan F. Bahin, Brian Chiang, Halim Awadie, Bronte Holt, Karen Byth, Michael J. Bourke

and Aims: Clinically significant bleeding (CSPEB) is the most frequent serious adverse event after endoscopic mucosal resection (EMR) of large laterally spreading colonic lesions (LSLs). There is no proven prophylactic therapy, and it remains a significant drawback of EMR. We aimed to systematically describe and evaluate the features of the post-EMR mucosal defect (PED) and their relationship to CSPEB. [...]

- R.S. Costa, J.M. Costa, A. Ferreira, R. Gonçalves, C. Rolanda


- Mark Beveridge, Sharan Wadhwani, James Chan, Vijay Sujendran, Edmund Godfrey


- Phillip R. Chisholm, Arpan H. Patel, Ryan J. Law, Allison R. Schulman, Arti O. Bedi, Richard S. Kwon, Erik J. Wamsteker, Michelle A. Anderson, Grace H. Elta, Shail M. Govani, Anoop Prabhu

Markedly elevated liver chemistries in patients presenting with acute calculous cholecystitis (AC) often prompt an evaluation for concomitant choledocholithiasis (CDL). However, current guidelines directing the workup for CDL fail to address this unique population. The aims of this study are to define the range of presenting lab values and imaging findings in AC, develop a model to predict the presence of concurrent CDL, and develop a management algorithm that can be easily applied on presentati [...]